Our technology has been named by WIRED as an innovative approach to stall SARS-CoVcampaign-pages/cd3/campaign-pages/cd3/-2, the virus that causes COVIDcampaign-pages/bispecifics/-19. We can rapidly identify antibodies against the virus by screening samples provided by patients who have recovered from the disease, using our high-throughput microfluidic platform and miniaturized assays.
